Aspirin Plus PPI Less Likely Than Clopidogrel To Cause GI Events – Study
This article was originally published in The Tan Sheet
Executive Summary
Results of a recent study support NSAID and proton pump inhibitor combinations as an alternative to clopidogrel as antiplatelet therapy for patients with GI ulcer risk
You may also be interested in...
Prevacid NapraPAC Scripts Suggest PPI/NSAID Combos May Thrive Post-Vioxx
TAP's Prevacid NapraPAC is among the early winners in the arthritis market following the withdrawal of Merck's Vioxx, IMS Health data suggest
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands